PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPsoriasis
MeSH D011565 - psoriasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D017444:Papulosquamous skin diseases
1 Company
1 Drug
$
Success rate
D011565: 
Psoriasis
124 Companies
56 Drugs
$
Success rate
D015535:Psoriatic arthritis
75 Companies
14 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyCortisone Cortisone  1982-01-01   
AbbVieCalcitriol Calcijex  1986-09-25   
Cyclosporine Cyclosporine  2000-03-03   
Cyclosporine Gengraf  2000-05-12   
Adalimumab Humira  2003-09-08 $10,615 M Q4/23-Q3/24 
Risankizumab Skyrizi  2019-04-23 $10,334 M Q4/23-Q3/24 
Cyclosporine Restasis Multidose 2024-08-27 2002-12-23   
Accord HealthcareMycophenolate mofetil Mycophenolate Mofetil  2009-05-04   
Mycophenolic acid Mycophenolic  2017-08-23   
Methotrexate Methotrexate  2007-04-30   
Alembic PharmaceuticalsMethotrexate Methotrexate  2024-06-03   
Acitretin Acitretin  2024-08-05   
Betamethasone Betamethasone  2024-08-22   
Alimera SciencesFluocinolone acetonide Iluvien 2027-08-12 2014-09-26   
Fluocinolone acetonide Yutiq 2027-08-12 2018-10-12   
Alkem LaboratoriesMycophenolate mofetil Mycophenolate Mofetil  2011-11-04   
Mycophenolic acid Mycophenolic  2021-09-23   
AllerganTazarotene Avage  2000-09-29   
Fluocinolone acetonide Fluonid  1984-09-06   
Tazarotene Tazorac  1997-06-13   
Betamethasone Betamethasone  1984-10-10   
Clotrimazole, Betamethasone Clotrimazole Betamethasone  2002-08-02   
Cortisone Cortisone  1982-01-01   
Fluocinolone acetonide Fluocinolone  2016-10-21   
Methoxsalen Methoxsalen  2015-06-09   
Betamethasone Valnac  1984-10-10   
AlmirallTildrakizumab Ilumetri  2018-09-17   
Dimethyl fumarate Skilarence  2017-06-23   
AlpharmaBetamethasone Betamethasone  1987-02-03   
Fluocinolone acetonide Fluocet  1984-01-16   
Fluocinolone acetonide Fluocinolone  1982-06-16   
American RegentBetamethasone Betamethasone Betamethasone  2009-07-31   
Calcitriol Calcitriol  2003-09-26   
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
56%
49/87
Phase 2
46%
49/107
Phase 3
76%
69/91
Approved: 37Overall Success rate: 20%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Adalimumab,
Risankizumab,
Cyclosporine,
Risankizumab-rzaa,
Benzylpenicillin,
Antithrombin iii,
Ademetionine,
Bevifimod,
Edodekin alfa,
Czp,
Dmard,
Antacid,
Arm1,
Betaloc,
Arm2,
Evidence
Accord Healthcare
Mycophenolate mofetil,
Mycophenolic acid
Alimera Sciences
Fluocinolone acetonide
Alkem Laboratories
Mycophenolate mofetil,
Mycophenolic acid
Allergan
Tazarotene,
Cortisone,
Cortisone acetate,
Azzalure
Almirall
Dimethyl fumarate,
Tildrakizumab,
Tildrakizumab-asmn,
Salicylic acid,
Benzocaine,
Doconexent,
Aspartame,
Edodekin alfa,
Lasw1835,
Czp,
LAS41004,
Daivonex,
Diprosone,
Evidence,
Mydfrin
Amgen
Adalimumab,
Apremilast,
Benzocaine,
Ademetionine,
Sodium chloride,
Aspartame,
Bevifimod,
ORDESEKIMAB,
PREZALUMAB,
AMG-557,
Corticoids,
AMG811,
Viaject,
Q2w,
Sfp,
Czp,
Dmard,
Arm1,
Arm2,
Daivonex,
Diprosone,
Evidence,
Etanerept
Amneal Pharmaceuticals
Mycophenolate mofetil,
Methotrexate,
Enoblituzumab,
Aspartame
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use